Lean Manufacturing has been implemented within the Janssen Supply Chain since 2012. By consistently applying the basic principles of this working method, we hope in the short-term to be able to manufacture more with the same resources. In order to guide the organization in this endeavor and to accelerate the process, a Lean Acceleration Team (LAT) was created at the beginning of 2013. 

Of course, manufacturing more with the same resources means cost savings, but it also means more pleasant working conditions for the employees. Lean manufacturing is a model that originated in the Japanese automotive industry. The concept is based on a culture of continuous improvement, whereby all actions are measured and compared, and where the staff in the workplace is given plenty of room for initiative. 

By introducing the Lean Culture to the teams, Janssen Supply Chain aims to simplify the work tasks and to improve performance. Lean Manufacturing focuses entirely on those tasks that actually add value while eliminating unneeded ballast. 

JnJ_deel2_DRIESLUYTEN15.jpg
Lean-Acceleratie-Team-2716.jpg

The Lean Acceleration Team (LAT) headed by Guy Mannaerts (in the center of the photograph).

It is in this way that the ‘visual factory’ fits within the Lean Manufacturing concept: by visualizing the production lines, the operators can see what volumes are being produced, how they are being produced and which obstacles are still present. It's like the dashboard of a car. You can't drive without it, because without it you drive blind. Everyone who mans a position where actions can be influenced – and that is almost everywhere – must know the facts and figures. That way well-considered choices can be made. In daily production meetings, problems are then quickly recognized and addressed. 

Durabilité
Économique

Janssen believes that strong corporate results, correct policies and focused activities pave the way towards economic sustainability. 

Janssen must constantly reinvent itself in order to cope with the structural and economic changes that affect its environment. This is why Janssen is committed to build partnerships within an open innovation model, and to the continuous alignment of its cost-competitiveness by only developing medicines with a high therapeutic added value. 

For Janssen this means specifically: being focused and a leader in research & development, and being efficient and progressive in terms of production with the aim of bringing new therapeutic solutions to patients quicker and at less expense, and implementing a growth strategy to ensure our continued investment in all these areas.